Self-Expandable Metal Stenting of Refractory Upper Gut Corrosive Strictures: A New Role for Endoscopy? by Manta, Raffaele et al.
Hindawi Publishing Corporation
Case Reports in Gastrointestinal Medicine
Volume 2011, Article ID 346413, 5 pages
doi:10.1155/2011/346413
Case Report
Self-Expandable Metal Stenting of Refractory UpperGut
Corrosive Strictures: A NewRole for Endoscopy?
Raffaele Manta,1 RitaConigliaro,1 Helga Bertani,1 MauroManno,1 AhmedSoliman,1
PaoloFedeli,2 andGabrioBassotti3
1Gastroenterology and Endoscopy Unit, S. Agostino Estense Civil Hospital, Baggiovara Modena, Italy
2Gastroenterology Unit, Santo Spirito Hospital, Rome, Italy
3Gastroenterology & Hepatology Section, Department of Clinical & Experimental Medicine, Perugia Medical University School, Italy
Correspondence should be addressed to Raﬀaele Manta, r.manta@ausl.mo.it
Received 26 May 2011; Accepted 15 June 2011
Academic Editors: T. Hirata and A. J. Lembo
Copyright © 2011 Raﬀaele Manta et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Caustic strictures of the gastrointestinal tract are often diﬃcult to treat, since relapses are frequent after medical or endoscopic
treatment. Thus, novel approaches are needed. We report here our experience with self-expandable metallic stents (SEMS) as a
new endoscopic approach in three patients with corrosive strictures of the upper gastrointestinal tract.
1.Introduction
Caustic injury to the upper gastrointestinal (GI) tract
represents a signiﬁcant medical and social problem [1]. In
pediatric patients, caustic ingestion is usually accidental [2],
whereasinadults,itismoreoftenintentional,associatedwith
suicide attempts, and usually involves strong acids [3, 4].
Although mortality is not high, there is a highly related
morbidityrate:causticingestionmaythuscauseperforations
and necrosis in the acute phase, while the late complications
include stricture formation, especially in the esophagus and
the antrum, and the development of esophageal and, rarely,
gastric carcinoma [5, 6].
Endoscopic management of caustic strictures of the
esophagus and the gastric antrum usually relies on dilatation
procedures [7–9], although alternative procedures may be
used as a ﬁrst therapeutic choice or when dilatation is not
eﬀective [10, 11].
In recent years, the use of endoscopic stenting for
nonneoplastic stenoses has been implemented, in both
pediatric and adult subjects [12–15].
We report three cases of corrosive injury of the upper
GI tract treated by self-expandable metal stents (SEMS)
positioning.
2.CaseSeries
2.1. Patient 1. A 50-year old woman with bipolar manic-
depressive syndrome was referred to our Endoscopy Unit
after voluntary ingestion of an unidentiﬁed volume and
concentration of muriatic acid. On admission, her main
complaint was chest pain; physical examination was normal.
ChestandabdomenX-rayﬁlmsdidnotrevealanyabnormal-
ities, and water soluble CT scan did not show perforation.
Upper endoscopy performed in the ﬁrst 24 hours after
ingestion showed multiple ulcers with extensive necrosis of
esophagus and stomach, while the duodenum was edema-
tous with some erosions and superﬁcial ulcerations (stage
3B and 2A, resp., according to the classiﬁcation of Zargar
and colleagues [16], Table 1). A central venous catheter was
inserted for nutritional support, and the patient was treated
with antibiotics and omeprazole, 40mg bid, i.v. The patient
was discharged one week later on oral omeprazole therapy.
After a month, she was admitted again due to vomiting.
Upper GI endoscopy, performed by a pediatric instrument
(Pentax EG-2930K), revealed two substenotic tracts of the
esophagus 15 and 35cm from the incisors. Fragility of
gastric mucosa and a 7cm antropyloric stricture were also
observed. An upper GI series revealed a decreased calibre2 Case Reports in Gastrointestinal Medicine
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Figure 1: (a) Conio stent placed across the cervical stenosis. (b) Radiologic control of stent positioning by water soluble contrast medium.
(c) Cervical esophageal lumen after stent removal: beyond the stenotic tract a decubitus ulcer is seen.
of the distal esophagus, the distal part of the antrum, and
pylorus. Pneumatic balloon dilation (CRE Boston Scientiﬁc
diameter 12–15 mm, at 6ATM) of the antropyloric stenosis
was carried out and repeated (balloon diameter 18–20 mm,
4–6ATM) after a month for recurrence of a 5cm stenosis.
At one-month followup, the stenosis was still present and
was retreated by balloon dilatation (diameter 12–15mm at
6ATM) followed by SEMS positioning (Taewoong pyloric
covered metallic stent, 18 × 60mm). After three months,
when planned SEMS extraction, the patient complained
of dysphagia. Endoscopy showed a cervical stricture and a
double stricture of the medium esophagus (22 and 30cm
from incisors, resp.), the latter successfully treated in one
session by Savary dilators (9 to 16mm) under ﬂuoroscopic
guidance, followed by intralesional corticosteroids injection
(triamcinolone acetonide 40mg/10mL). The cervical stric-
ture was treated in ﬁve endoscopic sessions by balloon
dilation (diameter up to 18mm, 4, 5ATM) and thereafter
by SEMS (Taewoong Conio-type stent: 16mm, 12cm)
placement because of the stricture recurrence (Figures 1(a)
and 1(b)). The stent dislodged distally after 2 days and
was removed endoscopically on the 3rd day (Figure 1(c)).
Restenosis did not occur after stent dislocation. Three
months later the pyloric metallic stent was removed after
freeing it with argon plasma coagulation (APC). At 24-
month followup no stricture recurrence was observed.
2.2. Patient 2. A 56-year old schizophrenic woman was
referred to our Endoscopy Unit with a diagnosis of pyloric
stenosis due to voluntary ingestion of about 500mL of caus-
ticsubstance(benzalconiumchlorideandmuriaticacidinan
unknown concentration). Esophagogram with water soluble
contrast did not show perforation of the viscus. Upper GI
Table 1: Zargar endoscopic classiﬁcation for caustic mucosal injury
(adapted from [7]).
Grade Deﬁnition
0 normal ﬁndings at endoscopy
1 edema and hyperemia of mucosa
2A friability, hemorrages, erosions, blisters, whitish
membranes, exudates and superﬁcial ulcerations
2B grade 2A plus deep discrete or circumferential
ulcerations
3A small scattered multiple ulcerations and areas of
necrosis (brown-black or greyish discoloration)
3B extensive necrosis
endoscopy showed hyperemia and edema of the prepyloric
and pyloric mucosa with narrowed but passable pylorus by
a standard endoscope. The mucosal injury was classiﬁed
as grade 1 according to the above classiﬁcation. Total
parenteral nutrition (TPN) was started together with i.v.
omeprazole, 40mg bid. At one-month followup, endoscopy
showed pyloric stricture. An upper GI series showed a
4cm long prepyloric stenosis. Pneumatic dilatation using
CRE balloon (Boston Scientiﬁc, diameter 12–15 at 6ATM)
was performed in three consecutive sessions, and a covered
SEMS (Taewoong Pyloric 18mm, 6cm) was placed under
ﬂuoroscopic guidance for stricture recurrence. The patient
was discharged after two days, and omeprazole, 20mg bid,
was prescribed. Three months later the SEMS was removed
after cutting and freeing with a clamp tissue overgrowth at
the edges of the metallic mesh. Subsequent endoscopy and
upperGIseriesrevealedresolutionofthestenosis.Afterthree
months, endoscopic followup showed a substenosis of theCase Reports in Gastrointestinal Medicine 3
pyloric tract that was retreated by balloon dilation (up to
18mm diameter at 4.5ATM). The patient was asymptomatic
after 6 months of followup.
2.3. Patient 3. A 38-year old man was admitted at our
Endoscopy Unit after voluntary ingestion of an unidentiﬁed
volume and concentration of muriatic acid. AC Ts c a n
with water soluble contrast did not show esophageal perfora-
tion. Upper GI endoscopy showed hyperemia, edema, and
friability associated to erosions of the cervical esophagus
and extensive necrosis of the stomach. The duodenal bulb
was very edematous with multiple erosions and superﬁcial
ulcerations (stages 2A and 3B, resp., according to the
above classiﬁcation). TPN was started together with i.v.
omeprazole, 40mg bid, and antibiotic therapy. After 20
days, GI endoscopy showed a double stenosis of cervical
esophagus and a pyloric stricture impassable with a pae-
diatric instrument. An upper GI series showed a 5.5cm
long prepyloric stenosis. Mechanic dilatation (Savary) up
to 16mm diameter followed by pneumatic dilatation with
CRE balloon (Boston Scientiﬁc, 12–15mm diameter at 4
and 6ATM) was performed, respectively, for esophageal and
pyloric strictures in two consecutive sessions. Thereafter,
a covered SEMS (Taewoong Pyloric 20mm, 8cm length)
was positioned in the antrum under ﬂuoroscopic guidance,
while the esophageal stenosis was resolved. The patient was
discharged after one week with omeprazole therapy, 20mg
bid. Two months later an endoscopic control showed that
the SEMS was almost free in the gastric cavity, and it
was extracted. Subsequently, an upper GI series revealed
resolution of the stenosis. After three months endoscopy
showed narrowing of the pyloric channel, well passable with
a standard endoscope (Pentax G-3030K). The patient was
asymptomatic after 6 months of followup.
3. Discussion
Corrosive agents are acid or alkaline compounds, with a
pH less than 2 or greater than 12 [6]. Alkali ingestion
causes more commonly esophageal injuries, whereas the
damage caused by acids is maximal in the stomach, and
the esophagus is minimally aﬀected [6, 17–19]. Both alkali
and acids penetrate tissues extremely rapidly and cause full
thickness damage to the gastrointestinal wall [6, 20, 21]. The
extentandseverityofcausticinjurydependsonthepHofthe
corrosive agent, its quantity and concentration, the physical
state of the caustic substance, the duration of exposure, and
the subsequent secondary infection [22].
Mucosal damage can occur up to 7 days after initial
injury, and then bacterial invasion, inﬂammatory response,
and development of granulation tissue ensue [23]. Scar
retraction begins in the third week and continues for several
months thereafter, leading to stricture and shortening of the
damaged segment [24, 25].
The initial assessment usually starts with a plain lateral
neck and chest radiographs, to exclude perforation; in
the absence of perforation, endoscopy is the diagnostic
p r o c e d u r eo fc h o i c e[ 19, 26]. Endoscopy should be per-
formed not prior than 6 hours (preferably within 12 hours)
after caustic ingestion, due to the high risk of iatrogenic
damage, and avoided 5 to 15 days after the ingestion,
due to wound softening during this period [16, 17, 23].
Identiﬁcation of the initial damage severity is of paramount
importanceformanagementandprognosis,sinceitallowsto
distinguishpatientswithnoevidenceofGIinjury,thatcanbe
discharged, from patients with severe injuries [17].
After ingestion of corrosive substances, 38% to 45%
of patients develop esophageal strictures; gastric outlet
obstruction is relatively uncommon, and it is usually found
in association with esophageal strictures (20% of cases)
[17, 27].
Concerning management, although many treatment
modalities have been suggested to prevent the development
of such complications, none has yielded univocal success
[28–31].
Periodic endoscopic dilation with bougies or balloons in
alternative to surgery is the traditional treatment for gas-
trointestinal stenosis due to corrosive agents [32]. Although
the success rate for esophageal strictures may be initially
high as to up 85% [33], following endoscopic dilations,
the chance of relapse is high and repeated procedures are
often required. Endoscopic dilations results are also good
in the short-term period for gastric strictures, but the mid-
and long-term therapeutic eﬃcacy is often unsatisfactory
[34]. The therapeutic success depends on both number and
frequency of dilation, balloon pressure, and the anatomy
of the strictures; although it has been suggested a step-up
dilation approach carried out every 2 weeks [35], it must
be taken into account the fact that dilations can increase
the ﬁbrotic activity of the second phase of wound healing.
Thus, intralesional corticosteroid therapy has been added to
dilations, showing beneﬁcial eﬀect for refractory strictures
due corrosive agents [36–40].
Over the last decade endoscopic stent insertion has been
proposed asanalternativetreatmenttorepeateddilations for
refractory benign esophageal stricture, prior to surgery.
Thus, the self-expandable plastic (SEPSs) and metallic
(SEMSs) stents have been used successfully as treatment
of benign strictures of the GI tract [14, 34, 41]. The use
of SEPS presents some advantages over SEMS, such as the
absence of a metal mesh and the completely covering silicone
membrane, that reduce mucosal overgrowth at the stent
edges and allow safe removal, even though the stent has been
in place for few months. Furthermore SEPSs, by a wider
surface and an higher expansive force, reduce the risk of
dislocation [41–43]; the limit of SEPS is that it is possible
to place them only into esophageal strictures.
SEMSs are commonly used for palliative treatment of
patients with malignant dysphagia, and have dramatically
reduced the morbidity of esophageal stent insertion com-
pared with that associated to the placement of rigid plastic
stents [44]. Also, SEMSs have been successfully used for
palliative treatment of malignant gastric outlet obstruction
[45].
SEMSs have never been proposed for benign caustic
strictures of pyloric region, as this kind of strictures is4 Case Reports in Gastrointestinal Medicine
relatively uncommon and also because the covered (totally
or partially) metal enteral stents have been available just
recently. The choice between totally or partially covered stent
is secondary to the stricture morphology and the probability
of stent dislocation, depending on how much the tract is
narrow and straight.
Here we report our experience with SEMS for the
treatmentofcausticupperGIstrictures.WeusedSEMSsince
we have a good experience (109 metallic stents positioned
in the last 5 years, with 12 of these procedures carried out
in patients with benign GI tract diseases. In these patients
SEMS were left in place for periods of 1–3 months, with
good results) in temporary SEMS placement for treatment
of esophageal, gastrojejunal anastomotic, and peptic pyloric
strictures.
The main problem for temporary metallic stent is to
determine the optimal placement period. Caustic strictures
are usually diﬃcult to treat because the granulation tissue
is very strong and plentiful; therefore, the longer the stent
is left in place, the more diﬃcult is to remove it [46]. In
our experience, we observed that, later than 4 weeks from
stent placement, granulation tissue grows within the distal
noncovered areas of the stent and within the stent covered
trunk, as a consequence of the silicon cover usury. Moreover,
we realized that it is impossible to remove stents without the
use of APC in a procedure that is surely time consuming
(about 60–90 minutes).
Endoscopy is the ﬁrst therapeutic approach of caustic
stenosis with either step-up mechanical or pneumatic dila-
tions;moreover,theplacementofendoscopicstents,thatmaybe
subsequently removed, has been established as an eﬀective way
to treat benign refractory strictures due to corrosive agents [47,
48]. In our cases SEMS positioning was eﬀective, probably
duetothestentradialexpansiveforceexerted,andinselected
cases, it might represent a new alternative treatment for
patients with caustic esophagogastric strictures. Transient
placement of a SEMS could signiﬁcantly improve prognosis
of patients with benign stenoses refractory to dilation
procedure. By the use of APC, SEMS can be removed after
a long period despite the development of tissue overgrowth
at the edges of the stent. This procedure must be performed
by skilled hands in referral endoscopic centers. Further
studies,alsowiththenewbiodegradablestents,areneededin
order to conﬁrm the eﬃcacy of this conservative endoscopic
technique [49].
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